Trials / Completed
CompletedNCT02533973
Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 951 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase 4 trial comparing the safety and efficacy of treatment with Xamiol® gel (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) once daily (as required) with Daivonex® scalp solution (calcipotriol 50 mcg/g) twice daily (as required) in Chinese subjects with scalp psoriasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xamiol® gel | |
| DRUG | Daivonex® scalp solution |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-03-06
- Completion
- 2018-03-06
- First posted
- 2015-08-27
- Last updated
- 2025-02-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02533973. Inclusion in this directory is not an endorsement.